The store will not work correctly when cookies are disabled.
N-(3-fluoro-4-methoxybenzyl)-8,9-dimethyl-8H-pyrazolo[3,4-h]quinazolin-4-amine
ID: ALA4635909
PubChem CID: 156014219
Max Phase: Preclinical
Molecular Formula: C19H18FN5O
Molecular Weight: 351.39
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(CNc2ncnc3c2ccc2nn(C)c(C)c23)cc1F
Standard InChI: InChI=1S/C19H18FN5O/c1-11-17-15(24-25(11)2)6-5-13-18(17)22-10-23-19(13)21-9-12-4-7-16(26-3)14(20)8-12/h4-8,10H,9H2,1-3H3,(H,21,22,23)
Standard InChI Key: XUKURYICSAOJCY-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
39.8853 -28.5672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.5949 -28.1578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.1772 -28.1583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.1784 -27.3417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.4022 -27.0882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.9213 -27.7481 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.4003 -28.4094 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.1509 -26.3106 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.1041 -27.7469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.8835 -26.9299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.5884 -27.3369 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.2913 -26.9299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.2904 -26.1161 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
40.5808 -25.7110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.8808 -26.1203 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
41.9995 -27.3377 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
42.7067 -26.9283 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.4149 -27.3361 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.4125 -28.1529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.1198 -28.5606 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.8281 -28.1511 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.8245 -27.3297 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.1166 -26.9257 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.5303 -26.9178 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
45.5368 -28.5580 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
45.5388 -29.3752 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3 1 1 0
1 2 2 0
2 11 1 0
10 4 1 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 1 0
7 3 2 0
5 8 1 0
6 9 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
12 16 1 0
16 17 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
22 24 1 0
21 25 1 0
25 26 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 351.39 | Molecular Weight (Monoisotopic): 351.1495 | AlogP: 3.58 | #Rotatable Bonds: 4 |
Polar Surface Area: 64.86 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 2.58 | CX LogP: 3.20 | CX LogD: 3.20 |
Aromatic Rings: 4 | Heavy Atoms: 26 | QED Weighted: 0.61 | Np Likeness Score: -1.48 |
References
1. Temple KJ, Long MF, Engers JL, Watson KJ, Chang S, Luscombe VB, Rodriguez AL, Niswender CM, Bridges TM, Conn PJ, Engers DW, Lindsley CW.. (2020) Discovery of structurally distinct tricyclic M4 positive allosteric modulator (PAM) chemotypes., 30 (4): [PMID:31787491] [10.1016/j.bmcl.2019.126811] |